InvestorsHub Logo
Followers 27
Posts 413
Boards Moderated 0
Alias Born 05/28/2018

Re: louieblouie post# 179621

Wednesday, 03/06/2019 1:44:51 PM

Wednesday, March 06, 2019 1:44:51 PM

Post# of 426643
LB, I don't have a background in pharma or pharma plant construction - let alone the regs for those associated topics in Europe, and North Asia.

What I have seen with respect to FSMA (Food Safety Modernization Act) is that a food factory can be revamped to meet FDA requirements in about a year or so. It's done by a box-in-a-box, essentially that puts a new shell on the inside of a factory. Again, that's not accounting for with respect to pharma grade oils whatever new pipes, columns, evaporators, in-take areas to prevent contamination, etc for processes that would also need to be upgraded.

I hope you don't mind, that I'd rather not make up a loose number that there's so many thousands of tons of pharma grade underutilized capacity available and that capacity currently going to DS will convert to 95% pharma purity capacity at such and such a rate over the next 10 years. Do I think there is excess capacity currently - yes and that bodes well for AMRN for the next couple of years.

Suppliers are going to want to see sales of V continue to shine to justify plant conversions where necessary, but IMO that's several years away.

PS - you were spot on, regarding posting to Federal Register rule changes after comment period...
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News